This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Fritiof Ponten: Innovator in Cardiac Treatment
Introduction
Fritiof Ponten is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of cardiac arrhythmias. His innovative work has led to the development of valuable compounds that can improve patient outcomes.
Latest Patents
Ponten holds a patent for oxabispidine compounds and their use in the treatment of cardiac arrhythmias. The patent describes compounds of formula (I), wherein R, R, R, R, R to R, A, B, and G have specific meanings provided in the description. These compounds are useful in the prophylaxis and treatment of arrhythmias, especially atrial and ventricular arrhythmias.
Career Highlights
Fritiof Ponten is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions for complex medical challenges. With a patent portfolio that includes 1 patent, Ponten has established himself as a key figure in pharmaceutical innovation.
Collaborations
Ponten has collaborated with notable colleagues, including Ulrik Gran and Peter Gustaf Bonn. These partnerships have contributed to the advancement of research and development in the field of cardiac treatment.
Conclusion
Fritiof Ponten's contributions to the medical field, particularly through his patented innovations, highlight his role as a significant inventor in cardiac arrhythmia treatment. His work continues to impact the lives of patients and the future of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
